DigiSight President and CEO Doug Foster explains how mobile technologies like his company’s SightBook app can help save patient vision and help the pharmaceutical industry develop new ophthalmology drugs.
Doug Foster is CEO of DigiSight Technologies. He has over 15 years experience identifying and developing technologies for the healthcare industry. Prior to DigiSight, Mr. Foster was a Managing Director at Longitude Capital, a venture capital firm dedicated to the life sciences. There he funded and helped develop technologies spanning most therapeutic areas with an emphasis on ophthalmology.